Ann Partridge, MD, MPH, FASCO
Patient participation in clinical trials is vital to advancing cancer research. Too often, however, a communication breakdown occurs between the physician and the patient. The result? Too many patients may never fully understand the research they took part in or the outcomes it yielded.
Conquer Cancer Announces 2023 Quality Care Symposium Merit Awards
ALEXANDRIA, Va. — Conquer Cancer®, the ASCO Foundation, is pleased to announce the recipients of its 2023 Quality Care Symposium Merit Awards.
Pedro Isaacsson Velho, MD
Prostate cancer is the second leading cause of cancer-related death among men in the U.S.* and the fourth most diagnosed cancer worldwide.* While the standard treatment — androgen deprivation therapy (ADT) — targets prostate cancer even in its advanced stages, most patients rapidly develop resist
Sarah Nyagabona, MD, MMed
In Tanzania, HIV infection and breast cancer are major concerns. It’s becoming critical to research the overlap between these two diseases.
Making an Impact for Childhood Cancer
“Many of these drugs are meant for adults, they’re not meant for children. These kids are taking things their grandparents took. It’s not right. It’s not acceptable.”
Dionisia Quiroga, DO, PhD
For patients with breast cancer, the effects of lymphedema can have a profound impact on quality of life.